EBERWINE JAMES has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are APPLIED BIOTECHNOLOGY INC, INTEGRAL MOLECULAR INC and GUANGZHOU REALBENEFITSPOT PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Eberwine James | 12 |
#2 | Sul Jai-Yoon | 5 |
#3 | Zeng Fanyi | 3 |
#4 | Haydon Philip G | 2 |
#5 | Langel Ulo | 2 |
#6 | Takano Hajime | 2 |
#7 | Wu Chia-Wen Kitty | 2 |
#8 | Zielinski Jennifer | 2 |
#9 | Kilk Kalle | 2 |
#10 | Miyashiro Kevin | 1 |
Publication | Filing date | Title |
---|---|---|
US2012129261A1 | Transcriptome transfer produces cellular phenotype conversion | |
US2013267678A1 | Transcriptome in vivo analysis | |
US2011033934A1 | Transcriptome transfer produces cellular phenotype conversion | |
US2010203629A1 | Cytoplasmic BKCa channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons | |
US2007105802A1 | Compositions and methods for modulating and monitoring neurotransmitter receptor populations |